ducovest

STVN:NYE- (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 20.42

Change

+0.13 (+0.64)%

Market Cap

USD 5.88B

Volume

0.21M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-31 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

 USD 65.91B
ALC Alcon AG

N/A

 USD 46.01B
RMD ResMed Inc

N/A

 USD 34.14B
BAX Baxter International Inc

N/A

 USD 18.71B
AVTR Avantor Inc

N/A

 USD 11.92B
ATR AptarGroup Inc

N/A

 USD 10.16B
TFX Teleflex Incorporated

N/A

 USD 6.39B
BLCO Bausch + Lomb Corp

N/A

 USD 5.64B
WRBY Warby Parker Inc

N/A

 USD 2.55B
INFU InfuSystems Holdings Inc

N/A

 USD 0.13B

ETFs Containing STVN

HCA:CA Hamilton Canadian Bank Me.. 21.51 % 0.00 %

N/A

 CAD 0.06B
ZEB:CA BMO S&P/TSX Equal Weight .. 15.69 % 0.60 %

N/A

 CAD 4.06B
CIC:CA CI Canadian Banks Covered.. 15.16 % 0.84 %

N/A

 N/A
BNC:CA Purpose Canadian Financia.. 11.84 % 0.68 %

N/A

 N/A
ZWB:CA BMO Covered Call Canadian.. 11.37 % 0.71 %

N/A

 CAD 3.02B
CEW:CA iShares Equal Weight Banc.. 9.35 % 0.60 %

N/A

 CAD 0.24B
RBNK:CA RBC Canadian Bank Yield I.. 7.89 % 0.33 %

N/A

 CAD 0.27B
HEF:CA 7.74 % 0.83 %

N/A

 N/A
HCB:CA 6.95 % 0.65 %

N/A

 N/A
BFIN-U:CA 5.72 % 0.00 %

N/A

 N/A
XDV:CA iShares Canadian Select D.. 5.49 % 0.55 %

N/A

 CAD 1.71B
QXM:CA First Asset Morningstar N.. 5.32 % 0.58 %

N/A

 CAD 0.08B
FIE:CA iShares Canadian Financia.. 4.95 % 0.97 %

N/A

 CAD 1.08B
NDIV:CA NBI Canadian Dividend Inc.. 4.55 % 0.00 %

N/A

 CAD 0.02B
PDC:CA Invesco Canadian Dividend.. 4.00 % 0.55 %

N/A

 CAD 0.79B
XFN:CA iShares S&P/TSX Capped Fi.. 3.90 % 0.61 %

N/A

 CAD 1.70B
MCLC:CA Manulife Multifactor Cana.. 3.26 % 0.45 %

N/A

 CAD 0.33B
FBE:CA 2.65 % 0.83 %

N/A

 N/A
XCSR:CA iShares ESG Advanced MSCI.. 2.30 % 0.00 %

N/A

 CAD 0.29B
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

N/A

 CAD 0.38B
DXIF:CA Dynamic Active Internatio.. 0.00 % 0.00 %

N/A

 CAD 7.71M

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.29% 58% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.29% 58% F 28% F
Trailing 12 Months  
Capital Gain -34.82% 32% F 9% A-
Dividend Return 0.19% 10% F 2% F
Total Return -34.64% 32% F 8% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.38% 86% B+ 65% D
Dividend Return 9.40% 86% B+ 58% F
Total Return 0.02% 8% B- 2% F
Risk Return Profile  
Volatility (Standard Deviation) 42.33% 43% F 22% F
Risk Adjusted Return 22.21% 81% B- 38% F
Market Capitalization 5.88B 47% F 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.